Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I/II results of DNase eye drops for dry eye disease

May 16, 2019

Emory University synthesizes fusion peptides including uPA or EGFR sequences with a toxin

May 16, 2019

FDA clears IND for Turning Point's TPX-0022

May 16, 2019

FDA approves Venclexta with Gazyva for previously untreated CLL or SLL

May 16, 2019

New phase I trial studies MK-8558 in antiretroviral-naive patients with HIV-1

May 16, 2019

FORMA Therapeutics discloses new HDAC6 inhibitors

May 16, 2019

Bayer describes new P2X purinoceptor 3 antagonists

May 16, 2019

New stroke therapy promotes motor recovery in mice

May 16, 2019

GABA-selective AAV therapy upregulates SCN1A to treat Dravet syndrome

May 16, 2019

Vertex and Kymera enter strategic research and development collaboration

May 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...